|
[1] Zhang Xiaoqin, Zhang Qing, Huang Lili, et al. Pien-Tze-Huang attenuates
neuroinflammation in cerebral ischaemia-reperfusion injury in rats through the
TLR4/NF-κB/MAPK pathway[J]. Pharmaceutical Biology, 2021,
59(1): 826-837. DOI:10.1080/13880209.2021.1942926.
[2] Wang Qiuhong, Kuang Haixue, Su Yang, et al. Naturally derived
anti-inflammatory compounds from Chinese medicinal plants[J]. Journal of
Ethnopharmacology, 2013, 146(1): 9-39. DOI:10.1016/j.jep.2012.12.013.
[3] Zhai Xuan, Wang Kangmin, Gao Xingyi, et al. Research progress on
chemical constituents and pharmacological activities ofMenispermi rhizoma[J]. Molecules, 2023, 28(6): 2701.
DOI:10.3390/molecules28062701.
[4] Zhang Yanfei, Guo Wei, Wen Yadan, et al. SCM-198 attenuates early
atherosclerotic lesions in hypercholesterolemic rabbitsviamodulation of the inflammatory and oxidative stress
pathways[J]. Atherosclerosis, 2012, 224(1): 43-50.
DOI:10.1016/j.atherosclerosis.2012.06.066.
[5] Liu Haichao, Zhang Xiangjian, Du Yuanyuan, et al. Leonurine protects
brain injury by increased activities of UCP4, SOD, CAT and Bcl-2, decreased
levels of MDA and Bax, and
ameliorated ultrastructure of mitochondria in experimental stroke[J]. Brain
Research, 2012, 1474: 73-81. DOI:10.1016/j.brainres.2012.07.028.
[6] Huang Hui, Xin Hong, Liu Xinhua, et al. Novel anti-diabetic effect of
SCM-198viainhibiting the hepatic
NF-κB pathway in db/db mice[J]. Bioscience Reports,
2012, 32(2): 185-195. DOI:10.1042/BSR20110017.
[7] Meng Shiyu, Song Zhiling, Tang Zhuang, et al. Surface-decorated
nanoliposomal leonurine targets activated fibroblast-like synoviocytes for
efficient rheumatoid arthritis therapy[J]. Biomaterials Science, 2023, 11(21):
7099-7113. DOI:10.1039/d3bm00911d.
[8] Bai Donghui, Sun Yujie, Li Qiong, et al. Leonurine attenuates
OVA-induced asthmaviap38 MAPK/NF-κB
signaling pathway[J]. International Immunopharmacology, 2023, 114: 109483.
DOI:10.1016/j.intimp.2022.109483.
[9] Jiang Wen, Zhao Tingting, Zhen Xiaolan, et al. Rapid determination of 9
tyrosine kinase inhibitors for the treatment of hepatocellular carcinoma in
human plasma by QuEChERS-UPLC-MS/MS[J]. Frontiers in Pharmacology, 2022, 13:
920436. DOI:10.3389/fphar.2022.920436.
[10] 华荣, 陈瑶. 益母草碱抑制NLRP3炎症小体过度激活调控巨噬细胞M1/M2表型分化[J]. 药学实践杂志, 2021, 39(2): 143-147.
DOI:10.12206/j.issn.1006-0111.202101003.
[11] He Zekun, Li Peng, Liu Pan, et al. Exploring stachydrine: From natural
occurrence to biological activities and metabolic pathways[J]. Frontiers in
Plant Science, 2024, 15: 1442879. DOI:10.3389/fpls.2024.1442879.
[12] Zhang Wenhui, Zhang Yingling, Chen Simin, et al. Trigonelline, an
alkaloid fromLeonurusjaponicushoutt., suppresses mast cell
activation and OVA-induced allergic asthma[J]. Frontiers in Pharmacology, 2021,
12: 687970. DOI:10.3389/fphar.2021.687970.
[13] 李治汉, 刘雪, 杨霞, 等. 西贝素通过下调cyclin D1-CDK4/CDK6-Rb-E2F信号通路抑制人胃癌HGC-27细胞增殖[J]. 中国病理生理杂志, 2026, 42(2): 264-273.
DOI:10.3969/j.issn.1000-4718.2026.02.007.
[14] Zhao Huakan, Wu Lei, Yan Guifang, et al. Inflammation and tumor
progression: Signaling pathways and targeted intervention[J]. Signal
Transduction and Targeted Therapy, 2021, 6: 263.
DOI:10.1038/s41392-021-00658-5.
[15] Wang Yuan, Chen Shujing, Du Kunze, et al. Traditional herbal medicine:
Therapeutic potential in rheumatoid arthritis[J]. Journal of Ethnopharmacology,
2021, 279: 114368. DOI:10.1016/j.jep.2021.114368.
[16] Chen L, Wang X, Zhang Y, et al. Leonurine alleviates OVA-triggered
allergic airway inflammation by suppressing p38 MAPK/NF-κB cascade
in asthmatic mice[J]. Journal of Cellular Physiology, 2024, 239 (5): 1124-1136.
DOI: 10.1002/jcp.31987
[17] Ma Hanjun, Zhao Shibo, Wei Yuxin, et al. Effect of the combination of
native herb with motherwort on anti-inflammatory, anti-fatigue, and
hypertensive hypoxia tolerance[J]. Current Research in Medical Sciences, 2023,
2(2): 16-22. DOI:10.56397/crms.2023.06.04.
[18] Mazgaeen L, Gurung P. Recent advances in lipopolysaccharide
recognition systems[J]. International Journal of Molecular Sciences, 2020,
21(2): 379. DOI:10.3390/ijms21020379.
[19] Wei Jiayi, Tang Lei, Wang Sijian, et al. TLR4 identified as a major
depressive disorder gene signature mediating effects through multiple immune
cells[J]. Scientific Reports, 2025, 15: 12437. DOI:10.1038/s41598-025-95663-x.
[20] Fisch D, Zhang Tian, Sun He, et al. Molecular definition of the
endogenous Toll-like receptor signalling pathways[J]. Nature, 2024, 631(8021):
635-644. DOI:10.1038/s41586-024-07614-7.
[21] Li Xue, Li Xiangrong, Huang Pengpeng, et al. Acetylation of TIR
domains in the TLR4-Mal-MyD88 complex regulates immune responses in sepsis[J].
The EMBO Journal, 2024, 43(21): 4954-4983. DOI:10.1038/s44318-024-00237-8.
[22] Salauddin M, Bhattacharyya D, Samanta I, et al. Role of TLRs as
signaling cascades to combat infectious diseases: A review[J]. Cellular and
Molecular Life Sciences, 2025, 82(1): 122. DOI:10.1007/s00018-025-05631-x.
[23] Hering M, Madi A, Sandhoff R, et al. Sphinganine recruits TLR4
adaptors in macrophages and promotes inflammation in murine models of sepsis
and melanoma[J]. Nature Communications, 15(1): 6067.
DOI:10.1038/s41467-024-50341-w.
[24] Wang Wensheng, Wang Yu, Wang Fengjie, et al. Gastrodin regulates the
TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and
microglial activation in an AD model[J]. Phytomedicine, 2024, 128: 155518.
DOI:10.1016/j.phymed.2024.155518.
[25] Wei Ziyun, Ni Xiao,
Cui He, et al. Engeletin attenuates the inflammatory responseviainhibiting TLR4-NFκB signaling pathway in Crohn’s disease-like colitis[J].
Journal of Ethnopharmacology, 2025, 336: 118733. DOI:10.1016/j.jep.2024.118733. |